EFFECT OF HUMAN RECOMBINANT MULLERIAN INHIBITING SUBSTANCE ON ISOLATED EPITHELIAL AND MESENCHYMAL CELLS DURING MULLERIAN DUCT REGRESSION IN THE RAT

被引:49
|
作者
TSUJI, M
SHIMA, H
YONEMURA, CY
BRODY, J
DONAHOE, PK
CUNHA, GR
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, CTR REPROD ENDOCRINOL, SAN FRANCISCO, CA 94143 USA
[3] MASSACHUSETTS GEN HOSP, DEPT SURG, BOSTON, MA 02114 USA
[4] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.1210/en.131.3.1481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of human recombinant Mullerian Inhibiting Substance (MIS) on the regression of the Mullerian duct (MD) of female rat fetuses was examined in vitro to determine whether MIS acts on MD epithelium and/or mesenchyme at the critical periods of sexual differentiation. Urogenital ridges (URs) of female rat fetuses at 14.5- to 18.5-days of gestation (plug day = 0) were cultured for 3 days with or without recombinant human MIS in CMRL 1066 medium with 10% female fetal calf serum. In URs from 14.5- and 15.5-day-old fetuses, the cranial portion of the MD regressed almost completely during the 3-day culture period in the presence of MIS, whereas the caudal half to third of the MD remained intact but tapered to a fine point cranially. MDs survived in URs from 16.5-day-old fetuses cultured in the presence of MIS except that the cranial portion of the MDs was deformed. MIS did not elicit regression of MDs in URs obtained from 17.5- and 18.5-day-old fetuses, but instead caused the MD epithelium to form bulges projecting into the mesenchyme. MD epithelium at 15.5-days of gestation was separated from the surrounding UR mesenchyme, and both components (MD epithelium and mesenchyme) were cultured separately for 3 days in the presence or absence of MIS. Both epithelial and mesenchymal cells survived in the presence or absence of MIS. MD epithelium formed typical epithelial colonies, whereas UR mesenchyme spread as fibroblastic cells. Analysis of labeling index after incorporation of [H-3] thymidine demonstrated that MD epithelial DNA synthesis was not influenced by MIS. In contrast, mesenchymal labeling index was reduced significantly by MIS. This effect of MIS on UR mesenchyme in conjunction with earlier histological observations of mesenchymal condensation during MD regression and an absence of direct effects of MIS on the epithelium suggests that MIS elicits its effect on the MD epithelium via the surrounding mesenchyme.
引用
收藏
页码:1481 / 1488
页数:8
相关论文
共 50 条
  • [21] Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
    Teixeira, J
    Kehas, DJ
    Antun, R
    Donahoe, PK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) : 13831 - 13838
  • [22] Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
    Meirelles, Katia
    Benedict, Leo Andrew
    Dombkowski, David
    Pepin, David
    Preffer, Frederic I.
    Teixeira, Jose
    Tanwar, Pradeep Singh
    Young, Robert H.
    MacLaughlin, David T.
    Donahoe, Patricia K.
    Wei, Xiaolong
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (07) : 2358 - 2363
  • [23] Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance
    Papakostas, Thanos D.
    Pieretti-Vanmarcke, Rafael
    Nicolaou, Fotini
    Thanos, Aristomenis
    Trichonas, George
    Koufomichali, Xanthi
    Anago, Kosisochukwu
    Donahoe, Patricia K.
    Teixeira, Jose
    MacLaughlin, David T.
    Vavvas, Demetrios
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 70 (01) : 32 - 38
  • [24] Mullerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells
    Lee, MM
    Seah, CC
    Masiakos, PT
    Sottas, CM
    Preffer, FI
    Donahoe, PK
    Maclaughlin, DT
    Hardy, MP
    ENDOCRINOLOGY, 1999, 140 (06) : 2819 - 2827
  • [25] MULLERIAN INHIBITING SUBSTANCE IN THE ADULT-RAT OVARY DURING VARIOUS STAGES OF THE ESTROUS-CYCLE
    UENO, S
    KURODA, T
    MACLAUGHLIN, DT
    RAGIN, RC
    MANGANARO, TF
    DONAHOE, PK
    ENDOCRINOLOGY, 1989, 125 (02) : 1060 - 1066
  • [26] MINIMAL ANTIPROLIFERATIVE EFFECT OF RECOMBINANT MULLERIAN INHIBITING SUBSTANCE ON GYNECOLOGICAL TUMOR-CELL LINES AND TUMOR EXPLANTS
    WALLEN, JW
    CATE, RL
    KIEFER, DM
    RIEMEN, MW
    MARTINEZ, D
    HOFFMAN, RM
    DONAHOE, PK
    VONHOFF, DD
    PEPINSKY, B
    OLIFF, A
    CANCER RESEARCH, 1989, 49 (08) : 2005 - 2011
  • [27] ISOLATION OF THE BOVINE AND HUMAN GENES FOR MULLERIAN INHIBITING SUBSTANCE AND EXPRESSION OF THE HUMAN-GENE IN ANIMAL-CELLS
    CATE, RL
    MATTALIANO, RJ
    HESSION, C
    TIZARD, R
    FARBER, NM
    CHEUNG, A
    NINFA, EG
    FREY, AZ
    GASH, DJ
    CHOW, EP
    FISHER, RA
    BERTONIS, JM
    TORRES, G
    WALLNER, BP
    RAMACHANDRAN, KL
    RAGIN, RC
    MANGANARO, TF
    MACLAUGHLIN, DT
    DONAHOE, PK
    CELL, 1986, 45 (05) : 685 - 698
  • [28] Identification of large-scale characteristic genes of Mullerian inhibiting substance in human ovarian cancer cells
    Nam, Suk Woo
    Jo, Yun Sung
    Eun, Jung Woo
    Song, Jae Yen
    Ryu, Ki Sung
    Lee, Jung Young
    Lee, Joon Mo
    MacLaughlin, David T.
    Kim, Jang Heub
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (05) : 589 - 596
  • [29] Identification of characteristic molecular signature of Mullerian inhibiting substance in human HPV-related cervical cancer cells
    Hwang, Seong Jin
    Suh, Min Jung
    Yoon, Joo Hee
    Kim, Mee Ran
    Ryu, Ki Sung
    Nam, Suk Woo
    Donahoe, Patricia K.
    MacLaughlin, David T.
    Kim, Jang Heub
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (04) : 811 - 820
  • [30] Extracellular domain of YWK-II, a human sperm transmembrane protein, interacts with rat Mullerian-inhibiting substance
    Tian, XY
    Sha, YS
    Zhang, SM
    Chen, YB
    Miao, SY
    Wang, LF
    Koide, SS
    REPRODUCTION, 2001, 121 (06) : 873 - 880